Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Polyrizon Ltd. ( (PLRZ) ) has shared an update.
On May 23, 2025, Polyrizon Ltd. announced receiving a Nasdaq delisting notice due to concerns over substantial shareholder dilution from a securities issuance. The company plans to request a hearing to appeal the decision, which will temporarily stay any suspension or delisting actions. This development could impact Polyrizon’s market presence and investor confidence as they navigate the Nasdaq’s regulatory requirements.
More about Polyrizon Ltd.
Polyrizon Ltd. is a development stage biotech company specializing in innovative intranasal hydrogels. Their primary products include medical device hydrogels delivered as nasal sprays, designed to form a protective barrier against viruses and allergens. The company’s proprietary Capture and Contain (C&C) technology acts as a ‘biological mask,’ while their Trap and Target (T&T) technology is focused on nasal delivery of active pharmaceutical ingredients.
Average Trading Volume: 20,756,645
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.66M
For a thorough assessment of PLRZ stock, go to TipRanks’ Stock Analysis page.